pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jun 30·1 min read
save

Health tech executives grow confident in AI, survey shows sharp shift in attitudes

Jun 30, 2026·read at Endpoints ↗Positive

A yearly survey conducted by Venrock partners Bob Kocher, Bryan Roberts and Siobhan Nolan Mangini reveals that confidence in using artificial intelligence within healthcare has risen sharply over the past twelve months.

The latest results contrast with the previous year, when many health-tech leaders expressed caution and uncertainty about AI's role in clinical settings.

The growing optimism suggests that investors and product teams may accelerate AI-driven initiatives, although the article notes that broader adoption still depends on regulatory clarity and proven outcomes.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Health AI caution crosses into confidence”

read at Endpoints ↗
81 words · retrieved Jul 1
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 58m agoMerck's top dealmaker signals more M&A as Keytruda's patent cliff nearsEndpoints
  • 4h agoNovartis' drug delivery deal with Alteogen; More worker cuts at CellaresEndpoints
  • 4h agoPfizer shares ADC rights with Medicus; RevMed updates lung cancer dataEndpoints
  • 4h agoAbbVie claims Phase 3 win for multiple myeloma drug etentamigEndpoints
  • 6h agoHealth tech investors are looking at bigger betsEndpoints